| Author (Corporate) | European Commission: DG Communication |
|---|---|
| Series Title | Press Release |
| Series Details | IP/12/884 (08.8.12) |
| Publication Date | 08/08/2012 |
| Content Type | News |
|
The European Commission has cleared under the EU Merger Regulation the proposed acquisition of the Dutch and German medical device company BSN Medical by the Guernsey based investment fund EQT VI, part of the EQT group of private equity funds. The Commission's investigation confirmed that the operation would not raise competition concerns because the parties have no overlapping activities. The Commission's investigation showed that no horizontal overlaps arise from the transaction, since neither EQT VI nor any company that EQT controls are active in the same field as BSN Medical. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/12/884&format=HTML&aged=0&language=EN&guiLanguage=en |
| Subject Categories | Internal Markets |
| Countries / Regions | Europe |